GPCR 241115 52.50C (GPCR241115C52500) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

GPCR241115C52500

Watchlist

0.40
-0.35-46.67%

15min DelayTrading Nov 4 10:37 ET

0.50High0.40Low

Intraday

5D
Daily

News

Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek 2024
GlobeNewswireOct 31 08:30 ET
Top Small-cap Stock Picks From Morgan Stanley Following the Group's Upgrade to Neutral
Seeking AlphaOct 21 14:52 ET
BMO Capital Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $100
Moomoo NewsOct 21 08:31 ET · Ratings
Consumer, Labor Groups Urge FTC to Block Catalent Sale to Novo Nordisk - Report
Seeking AlphaOct 17 15:30 ET
10 Health Care Stocks With Whale Alerts In Today's Session
BenzingaOct 16 13:35 ET
Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect?
Zacks Oct 9 09:05 ET

Comments

$Structure Therapeutics (GPCR.US)$
go go fly my loving stock

still uptrend..go buy target price $65

still uptrend..go buy target price $65

Share Your Profit/Loss

1

1

this one so hard to achieve 10% above. profit taken first.

Share Your Profit/Loss

3

1

$Structure Therapeutics (GPCR.US)$ hopefully the uptrend continues

Smid-cap obesity stocks hit by $RHHBY positive Ph1 data for oral GLP-1 obesity drug ⚠️

$ROCHE HOLDING AG (RHHBY.US)$
📣 Roche News Snippet:
» CT-996 led to significant weight loss (-7.3%) after 4 weeks 🆚 placebo (-1.2%)
» data supports once-daily oral dosing regimen
» Safety profile was similar to other GLP-1 drugs; no unexpected safety issues observed
Did you see today's sell-off? 🔴
$Eli Lilly and Co (LLY.US)$ $Novo-Nordisk A/S (NVO.US)$ $Structure Therapeutics (GPCR.US)$ $Viking Therapeutics (VKTX.US)$ $Lipocine (LPCN.US)$

Smid-cap obesity stocks hit by $RHHBY positive Ph1 data for oral GLP-1 obesity drug ⚠️

6

Read more